From American Rebel Holdings, Inc.’s (NASDAQ: AREB) beverage‑industry launch announcement in October 2023 to today, American Rebel Light Beer has executed a scalable rollout strategy—pairing it’s premium, “better‑for‑you” light lager differentiation with leading distribution relationships that power chain placements, high‑volume on‑premise accounts, and repeat consumer demand in a $110B+ U.S. beer market. NASHVILLE, Tenn., Feb. 19, 2026 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), America’s Patriotic Brand™, today issued a comprehensive launch‑to‑today recap for American Rebel Light Beer, highlighting key milestones since the Company announced its expansion into the beverage industry in October 2023 through the brand’s accelerating distribution footprint and retail...

The Supervisory Board of TKM Grupp AS approved today, on 19 February 2026 the annual report and profit allocation proposal for the year 2025 of TKM Grupp AS. The Supervisory Board decided to present the annual report and profit allocation proposal as prepared by the Management Board for the approval of the general meeting of shareholders. The revenues and profits remained unchanged compared to the preliminary disclosure on 16 January 2026. The original audited Annual Report 2025 document is submitted in machine-readable .xhtml format to the Nasdaq Tallinn Stock Exchange and digitally signed (Link: https://nasdaqbaltic.com/statistics/en/instrument/EE0000001105/reports). The consolidated audited revenue of TKM Grupp AS for the year of 2025 was 919.6 million euros. The revenue decreased by 2.6 per cent (the revenue for the year of 2024 was...

KUALA LUMPUR, Malaysia, Feb. 19, 2026 (GLOBE NEWSWIRE) — Sagtec Global Limited (NASDAQ: SAGT), an AI-native enterprise SaaS and automation platform provider, today announced continued expansion of its revenue-generating AI ecosystem as enterprise adoption accelerates across multiple industry verticals. Serving more than 12,000 businesses, Sagtec is transitioning toward a scalable platform-driven business model centered on recurring SaaS subscriptions, AI workflow automation, and integrated data infrastructure services. Management believes this evolution positions the Company to capture long-term monetization opportunities as enterprises shift away from legacy enterprise software stacks. Growing Enterprise Pipeline Strengthens Revenue VisibilityRecent commercial momentum includes a US$4.0 million Smart AI mobility platform deployment,...

Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry SALT LAKE CITY, Feb. 19, 2026 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced the publication of the analytical validation of the FirstGene® Multiple Prenatal Screen in Clinical Chemistry. The study showed that each component of the test had exceptional sensitivity and specificity. Titled “Simultaneous prenatal cfDNA screening of aneuploidy, recessive single-gene conditions, and fetomaternal blood compatibility,” the study used nearly 500 samples to assess the multiple components of the FirstGene screen, including fetal aneuploidy testing, RhD compatibility, and recessive condition status in the pregnant person and fetus, including 19 prevalent and severe...

DENVER, Feb. 19, 2026 (GLOBE NEWSWIRE) — ArrowMark Financial Corp. (NASDAQ: BANX) (the “Fund”) announced the preliminary results of its transferable rights offering (the “Offer”). The Offer commenced on January 22, 2026, and expired on February 18, 2026 (the “Expiration Date”).  The Offer entitled rights holders to subscribe for up to an aggregate of 2,604,156 of the Fund’s shares of common stock, par value $0.001 per share (“Common Shares”). The subscription price was $19.79 per Common Share and was determined based upon 90% of the Fund’s net asset value per Common Share at the close of trading on the NASDAQ Global Select Market on the Expiration Date. Common Shares will be issued promptly after receipt of all shareholder payments and completion of the pro-rata allocation of Common Shares in respect of the oversubscription privilege. Gross...

TORONTO, Feb. 19, 2026 (GLOBE NEWSWIRE) — M Split Corp. (“M Split”) declares its monthly distribution of $0.03125 per share ($0.375 annually) for Class I Preferred shareholders and a monthly distribution of $0.03125 per share for Class II Preferred shareholders. The Class I Preferred share dividends are paid at an annual rate of 7.50% based on the $5 notional issue price. The Class II Preferred share dividends are paid at an annual rate of 7.50% based on the $5 notional issue price when the NAV exceeds $10.00 Distributions are payable March 10, 2026 to shareholders on record as at February 27, 2026. M Split invests in common shares of Manulife Financial Corporation, the largest life insurer in Canada offering financial products and wealth management services.   Distribution Details Class I Preferred Share (YCM.PR.B) $0.03125Class...

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), today announced Chief Executive Officer Michael Castagna, PharmD is scheduled to present and share business updates during the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26, 2026, at 11:20 a.m. ET A link to the webcast of the presentation will be available on MannKind Corporation’s website at: https://investors.mannkindcorp.com/events-and-presentations. Recorded versions will also be available on the website for approximately 90 days following the conference. About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases,...